Literature DB >> 34302663

Generation of Efficient Knock-in Mouse and Human Pluripotent Stem Cells Using CRISPR-Cas9.

Tatsuya Anzai1,2, Hiromasa Hara1,3, Nawin Chanthra1, Taketaro Sadahiro4, Masaki Ieda4, Yutaka Hanazono1,5, Hideki Uosaki6,7.   

Abstract

A knock-in can generate fluorescent or Cre-reporter under the control of an endogenous promoter. It also generates knock-out or tagged-protein with fluorescent protein and short tags for tracking and purification. Recent advances in genome editing with clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated protein 9 (Cas9) significantly increased the efficiencies of making knock-in cells. Here we describe the detailed protocols of generating knock-in mouse and human pluripotent stem cells (PSCs) by electroporation and lipofection, respectively.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  CRISPR-Cas9; Genome editing; Homology-directed repair; Knock-in; Pluripotent stem cells

Year:  2021        PMID: 34302663     DOI: 10.1007/978-1-0716-1484-6_22

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  19 in total

1.  Multiplex genome engineering using CRISPR/Cas systems.

Authors:  Le Cong; F Ann Ran; David Cox; Shuailiang Lin; Robert Barretto; Naomi Habib; Patrick D Hsu; Xuebing Wu; Wenyan Jiang; Luciano A Marraffini; Feng Zhang
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

2.  RNA-guided human genome engineering via Cas9.

Authors:  Prashant Mali; Luhan Yang; Kevin M Esvelt; John Aach; Marc Guell; James E DiCarlo; Julie E Norville; George M Church
Journal:  Science       Date:  2013-01-03       Impact factor: 47.728

3.  Cotransformation and gene targeting in mouse embryonic stem cells.

Authors:  L H Reid; E G Shesely; H S Kim; O Smithies
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

4.  HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells.

Authors:  M Hooper; K Hardy; A Handyside; S Hunter; M Monk
Journal:  Nature       Date:  1987 Mar 19-25       Impact factor: 49.962

5.  An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.

Authors:  Keisuke Okita; Tatsuya Yamakawa; Yasuko Matsumura; Yoshiko Sato; Naoki Amano; Akira Watanabe; Naoki Goshima; Shinya Yamanaka
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

6.  Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.

Authors:  Bin-Kuan Chou; Prashant Mali; Xiaosong Huang; Zhaohui Ye; Sarah N Dowey; Linda Ms Resar; Chunlin Zou; Y Alex Zhang; Jay Tong; Linzhao Cheng
Journal:  Cell Res       Date:  2011-01-18       Impact factor: 25.617

7.  Expression of transgenes targeted to the Gt(ROSA)26Sor locus is orientation dependent.

Authors:  Douglas Strathdee; Helen Ibbotson; Seth G N Grant
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

8.  Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage.

Authors:  Jian-Ping Zhang; Xiao-Lan Li; Guo-Hua Li; Wanqiu Chen; Cameron Arakaki; Gary D Botimer; David Baylink; Lu Zhang; Wei Wen; Ya-Wen Fu; Jing Xu; Noah Chun; Weiping Yuan; Tao Cheng; Xiao-Bing Zhang
Journal:  Genome Biol       Date:  2017-02-20       Impact factor: 13.583

9.  Systematic gene tagging using CRISPR/Cas9 in human stem cells to illuminate cell organization.

Authors:  Brock Roberts; Amanda Haupt; Andrew Tucker; Tanya Grancharova; Joy Arakaki; Margaret A Fuqua; Angelique Nelson; Caroline Hookway; Susan A Ludmann; Irina A Mueller; Ruian Yang; Rick Horwitz; Susanne M Rafelski; Ruwanthi N Gunawardane
Journal:  Mol Biol Cell       Date:  2017-08-16       Impact factor: 4.138

10.  RNA-programmed genome editing in human cells.

Authors:  Martin Jinek; Alexandra East; Aaron Cheng; Steven Lin; Enbo Ma; Jennifer Doudna
Journal:  Elife       Date:  2013-01-29       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.